Skip to main content

Table 2 Metabolic Characteristics of all patients

From: Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population

  Case Control T2DM CHD
N 50 35 22
Fasting Glucose mmol/L 5.4(1.4) 15.4(5.4)a 5.6(0.6)
Cholesterol mmol/L 5.3(1.3) 6.9(1.9)b 7.7(2.7)c
HDL mmol/L 0.9(0.4) 0.88(0.3) 0.92(0.4)
Triglyceride mmol/L 1.8(0.6) 2.5(1.1) 2.1(1.2)
LDL mmol/L 3.9(1.4) 6.1(2.9)d 4.9(1.9)e
Insulin (Range) μmol/L* 7.5(5–12) 9.0(9–16) 7.0(1–49)
Leptin (Range)ng/mL* 7.2(2–30) 5.8(1.9–28) 3.7(0.7–8.9)
Apo1 mg/dL 80.1(15.6) 70.8.(23.4)c 74.1(24.5)
Apo11 mg/dL 48.7(13.5) 45.9(13.6)f 46.3(18.9)c
HOMAIR (Range)* 1.8(1.3–3.2) 8.2(0.8–49.7) 2.0(0.5–5.6)
Resistin ng/mL 18.9(3.4) 22.6(4.5)e 24.2(3.2)d
CRP (Range) μg/mL* 4.9(0.2–18.9) 8.2(0.7–27.1)g 7.3(1.8–18.3)f
  1. Data are presented as means (SD) or as median (interquartile range) for insulin, leptin HOMIR and CRP data. P-values shown are comparison of metabolic characteristics for case control versus either type 2 diabetic (T2DM) or coronary heart disease (CHD) patients as highlighted: a = p < 0.0001, b = p < 0.05, c = p < 0.003, d = p < 0.017, e = p < 0.01, f = p < 0.002, g = p < 0.007.